Zhen Xu

2.1k total citations · 1 hit paper
34 papers, 785 citations indexed

About

Zhen Xu is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Zhen Xu has authored 34 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Hematology. Recurrent topics in Zhen Xu's work include Epigenetics and DNA Methylation (7 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Zhen Xu is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Zhen Xu collaborates with scholars based in China, Australia and United States. Zhen Xu's co-authors include David C.S. Huang, Jianan Gong, Ian J. Majewski, Andrew W. Roberts, Rachel Thijssen, Christoffer Flensburg, Peter E. Czabotar, Piers Blombery, Ella R. Thompson and Tamia Nguyen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Zhen Xu

33 papers receiving 777 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

2018 276 citations Piers Blombery, Mary Ann Anderson et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhen Xu China	16	412	246	157	147	141	34	785
Jeffrey R. Shearstone United States	15	644 1.6×	139 0.6×	133 0.8×	138 0.9×	145 1.0×	27	1.0k
Takuji Yamauchi Japan	13	231 0.6×	222 0.9×	288 1.8×	130 0.9×	196 1.4×	50	772
Yujie Wu China	15	170 0.4×	298 1.2×	249 1.6×	236 1.6×	175 1.2×	91	681
Sonja Eberth Germany	14	310 0.8×	95 0.4×	89 0.6×	103 0.7×	107 0.8×	24	566
Crescenzio Francesco Minervini Italy	18	385 0.9×	187 0.8×	58 0.4×	62 0.4×	228 1.6×	56	761
Megan M. O’Meara United States	17	336 0.8×	104 0.4×	187 1.2×	255 1.7×	240 1.7×	34	952
Sanjai Sharma United States	16	472 1.1×	111 0.5×	92 0.6×	84 0.6×	259 1.8×	24	748
Paul Glover United States	13	250 0.6×	161 0.7×	95 0.6×	264 1.8×	68 0.5×	17	634
Hind Medyouf Germany	13	526 1.3×	108 0.4×	220 1.4×	56 0.4×	247 1.8×	23	976
Anuhar Chaturvedi Germany	18	665 1.6×	251 1.0×	108 0.7×	58 0.4×	614 4.4×	33	1.1k

Countries citing papers authored by Zhen Xu

Since Specialization

Citations

This map shows the geographic impact of Zhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Xu more than expected).

Fields of papers citing papers by Zhen Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Xu. The network helps show where Zhen Xu may publish in the future.

Co-authorship network of co-authors of Zhen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Xu. A scholar is included among the top collaborators of Zhen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Xu. Zhen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Li, Weibin Li, Zhen Xu, et al.. (2025). Promoting transcellular traversal of the blood–brain barrier by simultaneously improving cellular uptake and accelerating lysosomal escape. Nanoscale. 17(11). 6780–6792. 2 indexed citations

Zong, Ming, Zhen Xu, Qiunong Guan, et al.. (2025). Single-cell transcriptomic analysis of interactions of peritoneal mesenchymal stem cells with macrophages in prevention of peritoneal membrane injury. Biochemical and Biophysical Research Communications. 781. 152491–152491.

Behrens, Kira, Natalie Brajanovski, Zhen Xu, et al.. (2024). ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia. Science Advances. 10(10). eadj8803–eadj8803. 6 indexed citations

Wang, Yuting, Xiaoran Wang, Miaomiao Niu, et al.. (2024). Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer. Drug Design Development and Therapy. Volume 18. 5283–5297. 1 indexed citations

Zhu, Huijuan, Huimin Zhou, Xiaoxiao Zhou, et al.. (2024). Discovery of Novel 5-Cyano-3-phenylindole-Based LSD1/HDAC Dual Inhibitors for Colorectal Cancer Treatment. Journal of Medicinal Chemistry. 67(22). 20172–20202. 6 indexed citations

Zhang, Jingfang, Jingfang Zhang, Peng Jiang, et al.. (2023). Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma. Channels. 17(1). 2208928–2208928. 7 indexed citations

Xu, Zhen, Christoffer Flensburg, Rebecca A. Bilardi, & Ian J. Majewski. (2023). Uridine–cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine. Nucleic Acids Research. 51(22). 12031–12042. 5 indexed citations

Li, Yueyuan, Qing Liu, Ping Wang, et al.. (2023). An Electrochemical Immunosensor for Sensitive Detection of Cardiac Troponin I Based on the Amplification Effect of Asymmetric Bowl-Shaped Mesoporous Nanospheres. Journal of The Electrochemical Society. 170(7). 77508–77508. 1 indexed citations

Li, Xuejun, X. Sun, Jing Pang, et al.. (2022). Breast microbiome associations with breast tumor characteristics and neoadjuvant chemotherapy: A case-control study. Frontiers in Oncology. 12. 926920–926920. 10 indexed citations

10.

Xu, Zhen, et al.. (2022). Inversion Effect of Hand Postures: Effect of Visual Experience Over Long and Short Term. i-Perception. 13(3). 1243886839–1243886839. 1 indexed citations

11.

Xu, Zhen, Cassandra J. Vandenberg, Elizabeth Lieschke, et al.. (2021). CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors. Molecular Cancer Research. 19(8). 1350–1360. 11 indexed citations

12.

Xu, Zhen, Qian Zhao, Jinhui Lü, et al.. (2020). Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells. Pharmacological Research. 152. 104628–104628. 55 indexed citations

13.

Thijssen, Rachel, Silvia Álvarez-Díaz, Mingyuan Gao, et al.. (2020). Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells. Cell Death and Differentiation. 27(8). 2531–2533. 8 indexed citations

14.

Guo, Wei, et al.. (2019). Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation. Medicine. 98(16). e15228–e15228. 21 indexed citations

15.

Blombery, Piers, Mary Ann Anderson, Jianan Gong, et al.. (2018). Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia. Cancer Discovery. 9(3). 342–353. 276 indexed citations breakdown →

16.

Xu, Zhen, Phillip P. Sharp, Yuan Yao, et al.. (2016). BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. Leukemia. 30(7). 1531–1541. 25 indexed citations

17.

He, Yinghong, Gerhard Rank, Miaomiao Zhang, et al.. (2013). Induction of human fetal hemoglobin expression by adenosine-2’,3’-dialdehyde. Journal of Translational Medicine. 11(1). 14–14. 15 indexed citations

18.

Metcalf, Donald, Stefan Glaser, Zhen Xu, Ladina Di Rago, & Sandra Mifsud. (2013). Reversible growth factor dependency and autonomy during murine myelomonocytic leukemia induced by oncogenes. Proceedings of the National Academy of Sciences. 110(42). 17029–17034. 2 indexed citations

19.

Xu, Zhen, Xinxing Gao, Yinghong He, et al.. (2012). Synergistic Effect of SRY and Its Direct Target, WDR5, on Sox9 Expression. PLoS ONE. 7(4). e34327–e34327. 24 indexed citations

20.

Xu, Zhen, et al.. (2012). Interactions of Hydroxyapatite with Proteins and Its Toxicological Effect to Zebrafish Embryos Development. PLoS ONE. 7(4). e32818–e32818. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact